Neoadjuvant niraparib monotherapy for unresectable, homologous recombination deficiency-positive, high-grade serous ovarian cancer (NANT): a multicentre, single-arm, phase 2 trial

The Lancet Oncology · Elsevier

Аннотация

Publication date: November 2026 Source: The Lancet Oncology, Volume 27, Issue 11 Author(s): Dan Liu, Zikun Peng, Wei Zhang, Cui Feng, Ping Wang, Jundong Li, Yuanjia Wen, Wanying Shan, Yu Xia, Huayi Li, Bingquan Li, Ronghua Liu, Mingfu Wu, Zhen Li, Rong Liu, Gang Chen, Ya Wang, Xiaofei Jiao, Xiao Li, Cheng Liu

Читать у издателя →

Похожие статьи